Data for: A 73-gene Proliferative Transcriptomic Signature Predicts Uterine Serous Carcinoma Patient Survival and Response to Primary Therapy
Published: 07-05-2020| Version 1 | DOI: 10.17632/kjmmvtdssg.1
Contributors:
Description
De-identified uterine serous carcinoma patients' gene expression information and clinicodemographic information.